| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/27/2008 | US7378250 Monoclonal antibodies; hybridomas; malondialdehyde-modified (MDA); atherosclerosis |
| 05/27/2008 | US7378247 Tumor preferential polypeptide for use in the prevention treatment and diagnosis of cell proliferative disorders |
| 05/27/2008 | US7378237 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/27/2008 | US7378234 Method for isolating hepatitis C virus peptides |
| 05/27/2008 | US7378110 High pressure spray-dry of bioactive materials |
| 05/27/2008 | US7378101 Immunogenic mixture comprising porphyromonas inactivated whole cell preparation for use in generating immunotherapeutic protein for prevention and treatment of oral disease in companion animals |
| 05/27/2008 | US7378100 Fusion protein for inhibiting cervical cancer |
| 05/27/2008 | US7378099 Human papillomavirus polypeptides and immunogenic compositions |
| 05/27/2008 | US7378097 Use of penetration enhancers and barrier disruption methods to enhance the immune response of antigen and adjuvant |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | US7378094 Antibody complex comprising monoclonal antibody that specifically binds to complement receptor 2 linked to a second antibody that binds target antigen; anticarcinogenic agents, vaccines |
| 05/27/2008 | US7378093 Broadly cross-reactive neutralizing antibodies against Human Immunodeficiency Virus selected by Env-CD4-co-receptor complexes |
| 05/27/2008 | US7378092 Immunogenic compositions for induction of anti-tumor immunity |
| 05/27/2008 | US7378091 Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| 05/27/2008 | US7378090 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical PKM activity |
| 05/27/2008 | US7378089 Supplying suppressive genetic engineered cells; antiinflammatory agents |
| 05/27/2008 | US7378087 Method of enhancing an immune response |
| 05/27/2008 | CA2264895C Device and method for treating ophthalmic diseases |
| 05/27/2008 | CA2258494C Polypeptides capable of forming antigen binding structures with specificity for the rhesus d antigens, the dna encoding them and the process for their preparation and use |
| 05/27/2008 | CA2117181C Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 05/22/2008 | WO2008061243A2 Respiratory syncytial virus-virus like particle (vlps) |
| 05/22/2008 | WO2008060813A2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 05/22/2008 | WO2008060783A2 Ccr2 antagonists for treatment of fibrosis |
| 05/22/2008 | WO2008060669A2 Vaccine for avian influenza and methods of use |
| 05/22/2008 | WO2008060645A2 Combinatorial therapy involving alpha5beta1 antagonists |
| 05/22/2008 | WO2008060491A2 Anti-vegf treatment for radiation -induced vasculopathy |
| 05/22/2008 | WO2008060385A2 Li-key enhanced vaccine potency |
| 05/22/2008 | WO2008060371A1 USE OF TGF-β ANTAGONISTS TO TREAT INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |
| 05/22/2008 | WO2008060367A2 Human antibodies that bind cxcr4 and uses thereof |
| 05/22/2008 | WO2008060357A2 Methods of polypeptide production |
| 05/22/2008 | WO2008060219A1 Il- 18 vaccine for the treatment of various inflammatory conditions. |
| 05/22/2008 | WO2008059959A1 Nerve elongation promoter and elongation inhibitor |
| 05/22/2008 | WO2008059616A1 Antibody recognizing c-domain of midkine |
| 05/22/2008 | WO2008059314A1 Malaria vaccine based on the 200l subunit of the plasmodium vivax msp1 protein |
| 05/22/2008 | WO2008059018A2 Vaccine for vaccinating felines and canines against influenza virus |
| 05/22/2008 | WO2008058944A1 Microorganisms as carriers of nucleotide sequences coding for antigens and protein toxins, process of manufacturing and uses thereof |
| 05/22/2008 | WO2008058736A1 Lingo binding molecules and pharmaceutical use thereof |
| 05/22/2008 | WO2008058727A1 In vitro cultivation of helicobacter species |
| 05/22/2008 | WO2008058396A1 Papaya mosaic virus-based vaccines for influenza |
| 05/22/2008 | WO2008058381A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058369A1 Immunogenic affinity-conjugated antigen systems based on papaya mosaic virus and uses thereof |
| 05/22/2008 | WO2008036981A9 Methods for treating mica-related disorders |
| 05/22/2008 | WO2008030638A3 Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders |
| 05/22/2008 | WO2008024919A9 Interferon antagonists, antibodies thereto, and associated methods of use |
| 05/22/2008 | WO2008003007A3 Compositions and methods for treating parasitic infections |
| 05/22/2008 | WO2007144771A3 Peptides that mimic non-human cross-reactive protective epitopes of the group b meningococcal capsular polysaccharide |
| 05/22/2008 | WO2007137235A3 Apparatus, methods and systems for toxin delivery to the nasal cavity |
| 05/22/2008 | WO2007132480B1 A composition useful as a vaccine |
| 05/22/2008 | WO2007126439A3 Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling involving antibodies that bind to il-22 and il-22r |
| 05/22/2008 | WO2007117264A3 Compositions and methods for production of immunoglobulins |
| 05/22/2008 | WO2007114861A3 Il-21 receptor antagonists |
| 05/22/2008 | WO2007109747A3 Methods and compositions for antagonism of rage |
| 05/22/2008 | WO2007070430A3 Identification and application of antibiotic synergy |
| 05/22/2008 | WO2007054090A8 Therapeutic vaccines targeting hmgb1 |
| 05/22/2008 | WO2006124412A3 Methods for the rapid expansion of antigen specific t-cells |
| 05/22/2008 | WO2006059913A9 Modulation of ovulation |
| 05/22/2008 | US20080119399 An EGFR-reactive cytotoxic T lymphocyte which recognizes a complex between the EGFR-derived peptide and human leukocyte antigen (HLA) molecule; anticarcinogenic agent |
| 05/22/2008 | US20080119390 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 05/22/2008 | US20080118991 Method for isolating and purifying grass pollen allergens |
| 05/22/2008 | US20080118553 Tannate salt form of polypeptide mixtures, their preparation and use |
| 05/22/2008 | US20080118536 A carrier and a grass allergen purified by a combination of hydrophobic interaction chromatography, gel filtration and cation exchange chromatography; antiallergens; improved diagnosis of pollen allergies |
| 05/22/2008 | US20080118535 Surface protein of Neisseria bacteria |
| 05/22/2008 | US20080118534 Low dose, intramuscular injection of botulinum toxin |
| 05/22/2008 | US20080118533 Treatment of chronic chalazion and hordeolum with botulinum toxin |
| 05/22/2008 | US20080118532 Encoding anti-BoNT/B antibodies and a carrier selected from a keyhole limpet hemacyanin, an ovalbumin, a thyroglobulin, a bovine serum albumin or a soybean trypsin inhibitor |
| 05/22/2008 | US20080118531 Avian influenza viruses, vaccines, compositions, formulations, and methods |
| 05/22/2008 | US20080118530 In a human immunodeficiency virus, E coli, polio virus, a paramyxovirus, a rubella virus, or a coronavirus; increased phenotypic stability of attenuated vaccines; preventing vaccine-associated paralytic poliomyelitis |
| 05/22/2008 | US20080118529 Improves immunogenicity of vaccines for cancer, immunocastration, autoimmune diseases, atherosclerosis, amyloidoses, graft-versus-host rejections and transplant rejections |
| 05/22/2008 | US20080118528 Expressing a construct comprising the prM and E genes in a baculoviral expression cassette and cloned under the control of a promoter in insect cells; culturing; separation by lysis; diagnostic and therapeutic vaccines; vaccination |
| 05/22/2008 | US20080118527 Vaccine comprising hepatitis b viral antigen and hemophilus influenza b protein for use in prevention and treament of viral disease |
| 05/22/2008 | US20080118526 Chimeric osteogenic factor containing proteins capable of increased nuclear localization and methods of use thereof |
| 05/22/2008 | US20080118525 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 05/22/2008 | US20080118524 Anti-IgE Vaccines |
| 05/22/2008 | US20080118523 Chimeric polypeptide comprising tissue inhibitor of matrix metalloproteinases-3 (TIMP-3) for use in treatment and prevention of arthritic and degenerative joint disorders |
| 05/22/2008 | US20080118522 Using lymphocyte receptor specific immunoglobulins to treat and prevent viral infection, asthma, cardiovascular, autoimmune, cell proliferative and inflammatory disorders |
| 05/22/2008 | US20080118521 Using short intefering nucleotide sequences specific to helix-loop-helix protein (HEY-1) to treat and prevent osteoprosis and bone disorders; gene expression inhibition; antisense agents |
| 05/22/2008 | US20080118520 Variable heavy chains; immunoglobulins; neurodegenerative diseases |
| 05/22/2008 | US20080118519 Copper lowering treatment of inflammatory and fibrotic diseases |
| 05/22/2008 | US20080118518 Cancer stem cell-targeted cancer therapy |
| 05/22/2008 | US20080118517 Human monoclonal antibodies against interleukin 8 (IL-8) |
| 05/22/2008 | US20080118516 Using natural killer cell receptor modulators as therapeutic tools in prevention and treatment of viral diseases |
| 05/22/2008 | US20080118515 Regulatory T-Cells Containing Galectins for the Therapy and Diagnosis of Diseases |
| 05/22/2008 | US20080118514 Using toll-like receptor 4 specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory bowel, atherosclerotic and arthritic disorders |
| 05/22/2008 | US20080118513 Treatment of immune disorders with antibodies to costimulating polypeptide of T cells |
| 05/22/2008 | US20080118512 Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 05/22/2008 | US20080118511 PD-L2 Molecules: Novel PD-1 Ligands and Uses Therefor |
| 05/22/2008 | US20080118510 Vegf-related protein |
| 05/22/2008 | US20080118509 For directly inducing cell death without immune effector cells; antigens |
| 05/22/2008 | US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 05/22/2008 | US20080118507 Using intradermal injection to deliver therapeutic proteins to patients |
| 05/22/2008 | US20080118506 Humanized Anti-Factor D Antibodies and Uses Thereof |
| 05/22/2008 | US20080118505 Reagents and treatment methods for autoimmune diseases |
| 05/22/2008 | US20080118504 Pattern recogniton receptor for use in identifying modulator for treatment and prevention of sepsis, graft vs host, autoimmune, inflammatory and respiratory disorders |
| 05/22/2008 | US20080118503 Immunoglobulin specific to leptin receptor/leptin binding protein for use in prevention and treatment of eating, arthritic and autoimmune disorders |
| 05/22/2008 | US20080118502 Using metalloproteinase modulators as stimulatory tools in tissue regeneration; tissue engineering |
| 05/22/2008 | US20080118501 Antibodies with enhanced antibody-dependent cellular cytotoxicity activity, methods of their production and use |
| 05/22/2008 | US20080118500 Nanosphere contains phospholipid/cholesterol particle comprising vesicle, and agent-carrying component capable of forming complex with therapeutic agent via electrostatic charge-charge interaction or hydrophobic-hydrophobic interaction; cyclodextrins |
| 05/22/2008 | US20080118499 Using concentration of golgi-localized, gamma adaptin ear-containing, ARF-binding (GGA) as diagnostic indicator of beta-site amyloid precursor protein cleaving enzyme (BACE) activity and prognostic tool for detection of cardiovascular, nervous sytem and cell proliferative disorders |